Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-15 Sale | 2024-10-16 9:05 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO | 12,000 | $20.76 | $249,121 | 435,334 (Direct) | View |
| 2024-06-12 Sale | 2024-06-14 4:06 pm | Arcturus Therapeutics Holdings Inc. | ARCT | SASSINE ANDY Chief Financial Officer | 50,000 | $32.03 | $1,601,500 | 220,526 (Direct) | View |
| 2024-06-05 Sale | 2024-06-07 5:01 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO | 114 | $45 | $5,130 | 447,334 (Direct) | View |
| 2024-06-03 Sale | 2024-06-04 4:05 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO | 26,000 | $40.01 | $1,040,234 | 447,448 (Direct) | View |
| 2024-03-25 Sale | 2024-03-27 4:15 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO | 17,435 | $35.02 | $610,574 | 473,448 (Direct) | View |
| 2024-03-19 Sale | 2024-03-21 5:27 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO | 8,565 | $35.01 | $299,839 | 490,883 (Direct) | View |
| 2023-11-01 Sale | 2023-11-03 4:30 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO | 5,000 | $18.72 | $93,602 | 499,448 (Direct) | View |
| 2023-10-02 Sale | 2023-10-04 4:06 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO | 5,000 | $25.61 | $128,062 | 504,448 (Direct) | View |
| 2023-09-01 Sale | 2023-09-05 4:05 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO | 5,000 | $31.45 | $157,264 | 509,448 (Direct) | View |
| 2023-08-01 Sale | 2023-08-03 4:15 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO | 5,000 | $34.91 | $174,550 | 514,448 (Direct) | View |
| 2023-07-14 Sale | 2023-07-18 6:50 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO | 25,000 | $35.01 | $875,250 | 519,448 (Direct) | View |
| 2023-07-14 Sale | 2023-07-18 6:50 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks | 6,968 | $35 | $243,880 | 37,014 (Direct) | View |
| 2023-07-03 Sale | 2023-07-07 06:01 am | Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO | 5,000 | $28.75 | $143,750 | 544,448 (Direct) | View |
| 2023-06-01 Sale | 2023-06-05 4:07 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO | 5,000 | $27.16 | $135,800 | 549,448 (Direct) | View |
| 2023-05-10 Sale | 2023-05-12 4:05 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO | 25,000 | $30.08 | $751,902 | 554,448 (Direct) | View |
| 2023-05-01 Sale | 2023-05-03 4:08 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO | 5,000 | $25.93 | $129,650 | 579,448 (Direct) | View |
| 2023-04-18 Sale | 2023-04-19 4:57 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks | 6,968 | $28.18 | $196,358 | 43,982 (Direct) | View |
| 2023-04-03 Sale | 2023-04-05 8:47 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO | 5,000 | $25.38 | $126,900 | 584,448 (Direct) | View |
| 2023-03-06 Sale | 2023-03-08 9:34 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO | 5,000 | $16.07 | $80,350 | 589,448 (Direct) | View |
| 2022-12-15 Purchase | 2022-12-19 5:02 pm | Arcturus Therapeutics Holdings Inc. | ARCT | Marquet Magda Director | 2,222 | $18 | $39,996 | 24,942 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-19 Option Award | 2024-06-21 9:30 pm | N/A 2034-06-19 | Arcturus Therapeutics Holdings Inc. | ARCT | Slaoui Moncef Director | 29,794 | $0 | 29,794 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 9:01 pm | N/A 2034-06-14 | Arcturus Therapeutics Holdings Inc. | ARCT | Marantz Jing L. Director | 15,000 | $0 | 18,131 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-18 9:01 pm | N/A N/A | Arcturus Therapeutics Holdings Inc. | ARCT | Marantz Jing L. Director | 3,131 | $0 | 18,131 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 9:01 pm | N/A 2034-06-14 | Arcturus Therapeutics Holdings Inc. | ARCT | HOLMES EDWARD W Director | 15,000 | $0 | 18,131 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-18 9:01 pm | N/A N/A | Arcturus Therapeutics Holdings Inc. | ARCT | HOLMES EDWARD W Director | 3,131 | $0 | 18,131 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 9:00 pm | N/A 2034-06-14 | Arcturus Therapeutics Holdings Inc. | ARCT | Markels John Director | 15,000 | $0 | 18,131 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-18 9:00 pm | N/A N/A | Arcturus Therapeutics Holdings Inc. | ARCT | Markels John Director | 3,131 | $0 | 18,131 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 9:00 pm | N/A 2034-06-14 | Arcturus Therapeutics Holdings Inc. | ARCT | Marquet Magda Director | 15,000 | $0 | 43,073 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-18 9:00 pm | N/A N/A | Arcturus Therapeutics Holdings Inc. | ARCT | Marquet Magda Director | 3,131 | $0 | 43,073 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 9:00 pm | N/A 2034-06-14 | Arcturus Therapeutics Holdings Inc. | ARCT | BARLOW JAMES F Director | 15,000 | $0 | 28,131 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-18 9:00 pm | N/A N/A | Arcturus Therapeutics Holdings Inc. | ARCT | BARLOW JAMES F Director | 3,131 | $0 | 28,131 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 9:00 pm | N/A 2034-06-14 | Arcturus Therapeutics Holdings Inc. | ARCT | FARRELL PETER C Director | 15,000 | $0 | 113,696 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-18 9:00 pm | N/A N/A | Arcturus Therapeutics Holdings Inc. | ARCT | FARRELL PETER C Director | 3,131 | $0 | 113,696 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 8:01 pm | N/A 2033-12-15 | Arcturus Therapeutics Holdings Inc. | ARCT | SASSINE ANDY Chief Financial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 8:01 pm | N/A 2033-12-15 | Arcturus Therapeutics Holdings Inc. | ARCT | Chivukula Pad Chief Scientific Officer & COO | 125,000 | $0 | 125,000 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 8:01 pm | N/A 2033-12-15 | Arcturus Therapeutics Holdings Inc. | ARCT | Kurata Lance Chief Legal Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 8:00 pm | N/A 2033-12-15 | Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 8:00 pm | N/A 2033-12-15 | Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-08-15 Option Award | 2023-08-17 5:00 pm | N/A N/A | Arcturus Therapeutics Holdings Inc. | ARCT | SASSINE ANDY Chief Financial Officer | 1,223 | $17.37 | 270,526 (Direct) | View |
| 2023-08-01 Option Award | 2023-08-03 4:13 pm | N/A 2033-08-01 | Arcturus Therapeutics Holdings Inc. | ARCT | Markels John Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-08-01 Option Award | 2023-08-03 4:12 pm | N/A 2033-08-01 | Arcturus Therapeutics Holdings Inc. | ARCT | FARRELL PETER C Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-08-01 Option Award | 2023-08-03 4:12 pm | N/A 2033-08-01 | Arcturus Therapeutics Holdings Inc. | ARCT | Marantz Jing L. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-08-01 Option Award | 2023-08-03 4:11 pm | N/A 2033-08-01 | Arcturus Therapeutics Holdings Inc. | ARCT | HOLMES EDWARD W Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-08-01 Option Award | 2023-08-03 4:10 pm | N/A 2033-08-01 | Arcturus Therapeutics Holdings Inc. | ARCT | BARLOW JAMES F Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-08-01 Option Award | 2023-08-03 4:09 pm | N/A 2033-08-01 | Arcturus Therapeutics Holdings Inc. | ARCT | Marquet Magda Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-07-14 Exercise | 2023-07-18 6:50 pm | N/A N/A | Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks | 4,500 | $9.04 | 37,014 (Direct) | View |
| 2023-07-14 Exercise | 2023-07-18 6:50 pm | N/A N/A | Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks | 1,437 | $4.99 | 37,014 (Direct) | View |
| 2023-07-14 Exercise | 2023-07-18 6:50 pm | N/A N/A | Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks | 1,031 | $14.12 | 37,014 (Direct) | View |
| 2023-07-14 Exercise | 2023-07-18 6:50 pm | N/A 2028-07-04 | Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks | 6,968 | $0 | 37,014 (Direct) | View |
| 2023-04-18 Exercise | 2023-04-19 4:57 pm | N/A N/A | Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks | 4,500 | $9.04 | 43,982 (Direct) | View |
| 2023-04-18 Exercise | 2023-04-19 4:57 pm | N/A N/A | Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks | 1,437 | $4.99 | 43,982 (Direct) | View |
| 2023-04-18 Exercise | 2023-04-19 4:57 pm | N/A N/A | Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks | 1,031 | $14.12 | 43,982 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-19 4:57 pm | N/A 2030-02-18 | Arcturus Therapeutics Holdings Inc. | ARCT | Kummerfeld Keith C See Remarks | 6,968 | $0 | 43,982 (Direct) | View |